Author

Dong‐Kug Choi

Observed names: CK Choi, Choi Dong-Kug, Choi, Dong-Kug, D.-K. Choi, D.‐K. CHOI, D.‐K. Choi, Dong Kug Choi, Dong Kuk Choi, Dong-Kug CHOI, Dong-Kug Choi, Dongkug Choi

Institution: Konkuk University

Observed institutions: NewYork–Presbyterian Hospital, Inserm, Khon Kaen University, Cornell University, Konkuk University, Columbia University Irving Medical Center, Kyungpook National University, RIKEN, Pitié-Salpêtrière Hospital, Pediatrics and Genetics, Weill Cornell Medicine, Konkuk University Chungju Hospital, Physiopathologie des Comportements, Ajou University, University of Benin, The University of Tokyo, Columbia University

ORCID: 0000-0001-7041-1524

Observed ORCID: 0000-0001-7041-1524

OpenAlex ID: A5035360982

The DNA sequence of human chromosome 21

2000 · M. Hattori, A. Fujiyama, et al. · Nature · 1,474

PDF

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

2002 · Du Chu Wu, Vernice Jackson-Lewis, et al. · Journal of Neuroscience · 1,181

PDF

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

2003 · Peter Teismann, Kim Tieu, et al. · Proceedings of the National Academy of Sciences · 660

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

2004 · Gabriella Gardian, Susan E. Browne, et al. · Journal of Biological Chemistry · 456

Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases

2013 · Hemant Kumar, In-Su Kim, et al. · Natural Product Reports · 333

The role of glial cells in Parkinsonʼs disease

2001 · Miquel Vila, Vernice Jackson-Lewis, et al. · Current Opinion in Neurology · 326

Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms

2019 · Md. Jakaria, Shofiul Azam, et al. · Redox Biology · 315

PDF

Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice

2005 · Dong-Kug Choi, Subramaniam Pennathur, et al. · Journal of Neuroscience · 282

PDF

Pathogenic role of glial cells in Parkinson's disease

2002 · Peter Teismann, Kim Tieu, et al. · Movement Disorders · 275

The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration

2021 · Shofiul Azam, Md. Ezazul Haque, et al. · Frontiers in Cell and Developmental Biology · 255

PDF

Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease

2019 · Md. Ezazul Haque, Mahbuba Akther, et al. · Movement Disorders · 247

Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease

2007 · Celine Perier, Jordi Bové, et al. · Proceedings of the National Academy of Sciences · 229

PDF

Regulation of Toll-Like Receptor (TLR) Signaling Pathway by Polyphenols in the Treatment of Age-Linked Neurodegenerative Diseases: Focus on TLR4 Signaling

2019 · Shofiul Azam, Md. Jakaria, et al. · Frontiers in Immunology · 226

PDF

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease

2018 · Govindarajan Karthivashan, Palanivel Ganesan, et al. · Drug Delivery · 223

Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target

2016 · Sivapragasam Gothai, Palanivel Ganesan, et al. · Nutrients · 213

The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism

2012 · Hemant Kumar, Hyung-Woo Lim, et al. · International Journal of Molecular Sciences · 211

Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds

2020 · Rengasamy Balakrishnan, Dhanraj Vijayraja, et al. · Antioxidants · 204

PDF

Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases

2018 · Palanivel Ganesan, Prakash Ramalingam, et al. · International Journal of Nanomedicine · 184

PDF

Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

2006 · Mahmoud Kiaei, Susanne Petri, et al. · Journal of Neuroscience · 182

Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy

2016 · Palanivel Ganesan, Dong Kuk Choi · International Journal of Nanomedicine · 181

PDF

Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?

2015 · Hemant Kumar, Dong-Kug Choi · Mediators of Inflammation · 180

PDF

COX‐2 and Neurodegeneration in Parkinson's Disease

2003 · P. TEISMANN, M. VILA, et al. · Annals of the New York Academy of Sciences · 178

Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation

2016 · Gibok Lee, Hyung-Sik Won, et al. · Scientific Reports · 158

PDF

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

2015 · Sandeep Vasant More, Dong-Kug Choi · Molecular Neurodegeneration · 143

PDF

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease Model

2013 · Hemant Kumar, In-Su Kim, et al. · Evidence-based Complementary and Alternative Medicine · 128

PDF

Works count: 209

Citation count: 14,850

H-index: 60

I10-index: 157